Tae‐Yong Kim

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index

Younak Choi, Do‐Youn Oh, Tae‐Yong Kim et al. · PLoS ONE · 2015 · 242 citations · Full text

Medicine, Oncology, Chemotherapy +16

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

Ahrum Min, Seock‐Ah Im, Debora Keunyoung Kim et al. · Breast Cancer Research · 2015 · 177 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells

Ahrum Min, Seock‐Ah Im, Hyemin Jang et al. · Molecular Cancer Therapeutics · 2017 · 147 citations

Life Sciences, Oncology, Pharmacology +17

Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial

Yeon Hee Park, Tae‐Yong Kim, Gun Min Kim et al. · The Lancet Oncology · 2019 · 130 citations

Medicine, Oncology, Pharmacology +16

Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas

Geum‐Youn Gwak, Jung‐Hwan Yoon, Chang-Yup Shin et al. · Journal of Cancer Research and Clinical Oncology · 2005 · 108 citations · Full text

Medicine, Molecular Biology, Oncology +12